Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of an AI-Driven CT Angiography Model on Intracranial Aneurysm Detection and Clinical Outcomes in Regional Hospitals (IDEAL2): A Nationwide Stepped-Wedge Cluster-Randomized Trial

NCT07124624 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT07124624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07124624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of an AI-Driven CT Angiography Model on Intracranial Aneurysm Detection and Clinical Outcomes in Regional Hospitals (IDEAL2): A Nationwide Stepped-Wedge Cluster-Randomized Trial
Lead sponsor
Jinling Hospital, China
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 9, 2025
Completion date
August 31, 2029
Enrollment
14,400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ai (artificial intelligence), cluster randomized trial, ct angiography, intracranial aneurysm